Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
103 JPY
5.53 B JPY
26.45 B JPY
18.32 M
About SHIN NIPPON BIOMEDICAL LABORATORIES
Sector
CEO
Ryoichi Nagata
Website
Headquarters
Tokyo
Founded
1957
ISIN
JP3379950003
FIGI
BBG000K9PGS4
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: Preclinical Business, Clinical Business, Translational Research Business, Medipolis Business, and Others. The Preclinical Business segment verifies the efficacy and safety of new drugs using experimental animals and bacterial cells. The Clinical Business segment provides the support services for clinical trials and related statistical, analytical, and consulting services for all aspects of new drug development. The Translational Research Business segment utilizes drug and device development capabilities to accelerate drug development which leads to out-licensing to pharmaceutical companies. The Medipolis Business segment deals with the property management and geothermal power generation businesses. The Others segment engages in the information collection in Europe, which includes real estate and environmental equipment operations. The company was founded in April 1957 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2395 is 1,470 JPY — it has increased by 8.62% in the past 24 hours. Watch SHIN NIPPON BIOMEDICAL LABORATORIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SHIN NIPPON BIOMEDICAL LABORATORIES stocks are traded under the ticker 2395.
2395 stock has risen by 7.75% compared to the previous week, the month change is a 7.75% rise, over the last year SHIN NIPPON BIOMEDICAL LABORATORIES has showed a −13.33% decrease.
We've gathered analysts' opinions on SHIN NIPPON BIOMEDICAL LABORATORIES future price: according to them, 2395 price has a max estimate of 1,180.00 JPY and a min estimate of 1,180.00 JPY. Watch 2395 chart and read a more detailed SHIN NIPPON BIOMEDICAL LABORATORIES stock forecast: see what analysts think of SHIN NIPPON BIOMEDICAL LABORATORIES and suggest that you do with its stocks.
2395 reached its all-time high on Mar 6, 2023 with the price of 3,225 JPY, and its all-time low was 185 JPY and was reached on Nov 25, 2011. View more price dynamics on 2395 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2395 stock is 9.26% volatile and has beta coefficient of 1.04. Track SHIN NIPPON BIOMEDICAL LABORATORIES stock price on the chart and check out the list of the most volatile stocks — is SHIN NIPPON BIOMEDICAL LABORATORIES there?
Today SHIN NIPPON BIOMEDICAL LABORATORIES has the market capitalization of 51.67 B, it has increased by 2.22% over the last week.
Yes, you can track SHIN NIPPON BIOMEDICAL LABORATORIES financials in yearly and quarterly reports right on TradingView.
SHIN NIPPON BIOMEDICAL LABORATORIES is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
2395 earnings for the last quarter are 29.04 JPY per share, whereas the estimation was 26.89 JPY resulting in a 7.99% surprise. The estimated earnings for the next quarter are 21.80 JPY per share. See more details about SHIN NIPPON BIOMEDICAL LABORATORIES earnings.
SHIN NIPPON BIOMEDICAL LABORATORIES revenue for the last quarter amounts to 6.96 B JPY, despite the estimated figure of 5.41 B JPY. In the next quarter, revenue is expected to reach 8.40 B JPY.
2395 net income for the last quarter is 1.21 B JPY, while the quarter before that showed 122.19 M JPY of net income which accounts for 889.31% change. Track more SHIN NIPPON BIOMEDICAL LABORATORIES financial stats to get the full picture.
SHIN NIPPON BIOMEDICAL LABORATORIES dividend yield was 3.29% in 2023, and payout ratio reached 37.63%. The year before the numbers were 1.82% and 34.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 7, 2024, the company has 1.34 K employees. See our rating of the largest employees — is SHIN NIPPON BIOMEDICAL LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHIN NIPPON BIOMEDICAL LABORATORIES EBITDA is 4.03 B JPY, and current EBITDA margin is 22.80%. See more stats in SHIN NIPPON BIOMEDICAL LABORATORIES financial statements.
Like other stocks, 2395 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHIN NIPPON BIOMEDICAL LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHIN NIPPON BIOMEDICAL LABORATORIES technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHIN NIPPON BIOMEDICAL LABORATORIES stock shows the neutral signal. See more of SHIN NIPPON BIOMEDICAL LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.